Electrophoretic mobility shift assays (EMSAs) were used to assess the regulation of Oct-4/Sox2 by CDX2. Probes with the CDX2-binding site sequence (see Table 1) were labeled with Digoxigenin-11-deoxyuridine 5-triphosphate (DIG-ddUTP). Cell protein-DNA complexes were examined with and without competitors or the anti-CDX2 antibody. After electrophoretic separation, the complexes were probed auto-radiographically using a 2nd-generation DIG Gel Shift Kit (Roche, Mannheim, Germany).